Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Nick Loporcaro
AddedMar 31, 2024
UpdatedJun 28, 2026
Nick Loporcaro

Nick Loporcaro

CEO, Global Medical Response

Nick Loporcaro's Career

Global Medical Response
Global Medical Response

Greenwood Village, CO, US

CEO· C-Suite · Management
Medalogix
Medalogix

Nashville, TN, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Nick Loporcaro's Career

Global Medical Response
Global Medical Response
Public1.5k2018Greenwood Village, CO, US
CEO· C-Suite · Management

Leadership at Global Medical Response

Johnny KimJohnny KimBoard Member

Similar to Global Medical Response

DocGoDocGoNew York City, NY, USMedical Services, Transportationest. 2016DocGoNew York City, NY, US · est. 2016

DocGo: Leading provider of mobile medical services and transportation, innovating healthcare in the US and UK.

Public3.2k
Remote Medical InternationalRemote Medical InternationalSeattle, WA, USMedical Servicesest. 2003Remote Medical InternationalSeattle, WA, US · est. 2003

Remote Medical International: Your single-solution provider for global remote medical needs.

Series A · $8M81
US Acute Care SolutionsUS Acute Care SolutionsCanton, OH, USHealthcare, Hospitalistest. 2015US Acute Care SolutionsCanton, OH, US · est. 2015

U.S. Acute Care Solutions, LLC: Quality healthcare services provider for patients across the U.S.

Private Equity · $470.5M5.6k
Ready RespondersReady RespondersNew Orleans, LA, USHealthcare, Telemedicineest. 2016Ready RespondersNew Orleans, LA, US · est. 2016

Ready: Transforming healthcare by delivering accessible, direct medical care services.

Series C · $107.4M750
Medalogix
Medalogix
Private Equity$5.3M792009Nashville, TN, US
Board Member· Board

Leadership at Medalogix

Elliott WoodElliott WoodCEO
Dan HoganDan HoganFounder
Bradford Kyle ArmbresterBradford Kyle ArmbresterBoard Member

Similar to Medalogix

MedaxionMedaxionNashville, TN, USAnesthesia Softwareest. 2008MedaxionNashville, TN, US · est. 2008

Medaxion: A healthcare tech company offering real-time anesthesia intelligence solutions.

Series B · $27.5M40
Medically HomeMedically HomeBoston, MA, USMedical Careest. 2016Medically HomeBoston, MA, US · est. 2016

Medically Home: Tech-enabled clinical enterprise shifting hospital care to patients' homes.

Late Stage Private · $274.5M365
MedAuxMedAuxNew York City, NY, USHealthcare, Patient Engagementest. 2017MedAuxNew York City, NY, US · est. 2017

MedAux: A digital follow-up program for healthcare providers, enhancing patient engagement and data collection.

Seed · $100k4
HealthOpXHealthOpXEast Lansing, MI, USAnalytics Softwareest. 2019HealthOpXEast Lansing, MI, US · est. 2019

HealthOpX offers predictive analytics software for health systems, aiding community engagement and health improvement.

Angel · $220k6

Nick Loporcaro's Co-Investors

Sylvia RommSylvia RommCo-invested · Ilant Health AngelNitesh BantaNitesh BantaCo-invested · Ilant Health AngelIyah RommIyah RommCo-invested · Ilant Health AngelDavid WerryDavid WerryCo-invested · Ilant Health AngelBrandon KernsBrandon KernsCo-invested · Ilant Health AngelMatt KlitusMatt KlitusCo-invested · Ilant Health Angel

Nick Loporcaro's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Nick Loporcaro

Dan ScavillaDan ScavillaCEO · Globus MedicalRonald GoldRonald GoldBoard Member · NJ BioLevon Paul ThoroseLevon Paul ThoroseCEO · Global InnovationsGary ThompsonGary ThompsonFounder & CEO · Medical Technologies InternationalJim PearsonJim PearsonBoard Member · NicoJohn GrayJohn GrayCEO · Medical Quest